Illumina ILMN

HealthcareMarket cap $41B4 connections

Illumina makes the DNA sequencing instruments used in virtually every genomics lab worldwide - 90%+ market share. A single Illumina NovaSeq can sequence a human genome for $200 in hours, down from $100M when the Human Genome Project finished. Its technology enables cancer genomics, prenatal testing, infectious disease surveillance, and agricultural breeding programs. DNA sequencing is becoming routine medicine.

Open Illumina's Company Hub Simulate a merger Supply chain See it on the map

Customers 4

Companies Illumina sells to

AmgenHealthcare · $224BGenomics research platform
Vertex PharmaHealthcare · $133BGenomic sequencing for CF research
NateraHealthcare · $60BNatera uses Illumina sequencers for genetic tests
CRISPR TherapeuticsHealthcare · $5BIllumina sequencing for CRISPR gene validation

Other Healthcare companies

Eli Lilly Johnson & Johnson AbbVie Novo Nordisk Merck UnitedHealth Thermo Fisher AstraZeneca Amgen Novartis

Embed this on your site

Show Illumina's network in an article or report - it updates as our data does.

<iframe src="https://vexmap.com/embed.html?co=ILMN" width="600" height="420" style="border:0;border-radius:12px;max-width:100%" title="Illumina on VexMap" loading="lazy"></iframe>

Preview

Relationships are compiled by VexMap from company filings, announcements and reporting, and last reviewed September 2026. Spotted something wrong? Tell us. Not investment advice.